Annual EBIT
-$77.14 M
-$25.62 M-49.74%
31 December 2022
Summary:
Rain Therapeutics annual earnings before interest & taxes is currently -$77.14 million, with the most recent change of -$25.62 million (-49.74%) on 31 December 2022. During the last 3 years, it has fallen by -$56.19 million (-268.23%).RAIN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$8.08 M
+$12.32 M+60.39%
30 September 2023
Summary:
Rain Therapeutics quarterly earnings before interest & taxes is currently -$8.08 million, with the most recent change of +$12.32 million (+60.39%) on 30 September 2023.RAIN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$73.77 M
+$10.33 M+12.29%
30 September 2023
Summary:
Rain Therapeutics TTM earnings before interest & taxes is currently -$73.77 million, with the most recent change of +$10.33 million (+12.29%) on 30 September 2023.RAIN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RAIN EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -268.2% | +56.2% | -89.8% |
| 5 y5 years | - | - | - |
RAIN EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | +611.5% | +218.3% | +2806.7% |
Rain Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$8.08 M(-60.4%) | -$73.77 M(-12.3%) |
| June 2023 | - | -$20.39 M(-6.2%) | -$84.11 M(+3.3%) |
| Mar 2023 | - | -$21.74 M(-7.7%) | -$81.43 M(+5.6%) |
| Dec 2022 | -$77.14 M(+49.7%) | -$23.56 M(+28.0%) | -$77.14 M(+7.6%) |
| Sept 2022 | - | -$18.41 M(+3.9%) | -$71.66 M(-0.0%) |
| June 2022 | - | -$17.72 M(+1.5%) | -$71.68 M(+15.3%) |
| Mar 2022 | - | -$17.45 M(-3.5%) | -$62.15 M(+20.7%) |
| Dec 2021 | -$51.51 M | -$18.08 M(-2.0%) | -$51.51 M(+32.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$18.44 M(+125.2%) | -$38.88 M(+26.2%) |
| June 2021 | - | -$8.19 M(+20.3%) | -$30.82 M(+22.2%) |
| Mar 2021 | - | -$6.81 M(+25.1%) | -$25.22 M(+20.4%) |
| Dec 2020 | -$20.95 M(+92.7%) | -$5.44 M(-47.5%) | -$20.95 M(+35.1%) |
| Sept 2020 | - | -$10.38 M(+300.4%) | -$15.50 M(+202.3%) |
| June 2020 | - | -$2.59 M(+2.1%) | -$5.13 M(+102.1%) |
| Mar 2020 | - | -$2.54 M | -$2.54 M |
| Dec 2019 | -$10.87 M | - | - |
FAQ
- What is Rain Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Rain Therapeutics?
- What is Rain Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Rain Therapeutics?
- What is Rain Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Rain Therapeutics?
What is Rain Therapeutics annual earnings before interest & taxes?
The current annual EBIT of RAIN is -$77.14 M
What is the all time high annual EBIT for Rain Therapeutics?
Rain Therapeutics all-time high annual earnings before interest & taxes is -$10.84 M
What is Rain Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of RAIN is -$8.08 M
What is the all time high quarterly EBIT for Rain Therapeutics?
Rain Therapeutics all-time high quarterly earnings before interest & taxes is -$2.54 M
What is Rain Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of RAIN is -$73.77 M
What is the all time high TTM EBIT for Rain Therapeutics?
Rain Therapeutics all-time high TTM earnings before interest & taxes is -$2.54 M